Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease.
Delfino D, Mori G, Rivetti C, Grigoletto A, Bizzotto G, Cavozzi C, Malatesta M, Cavazzini D, Pasut G, Percudani R.
Delfino D, et al. Among authors: cavazzini d.
Biomolecules. 2021 Mar 10;11(3):410. doi: 10.3390/biom11030410.
Biomolecules. 2021.
PMID: 33802146
Free PMC article.